Insulin glargine-aglr

FDA Drug Profile — REZVOGLAR KWIKPEN, Rezvoglar KwikPen

Drug Details

Generic Name
Insulin glargine-aglr
Brand Names
REZVOGLAR KWIKPEN, Rezvoglar KwikPen
Application Number
BLA761215
Sponsor
A-S Medication Solutions
NDC Codes
2
Dosage Forms
INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients
INSULIN GLARGINE

Indications and Usage

1 INDICATIONS AND USAGE REZVOGLAR™ is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. Limitations of Use REZVOGLAR is not recommended for the treatment of diabetic ketoacidosis. REZVOGLAR™ is a long-acting human insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. ( 1 ) Limitations of Use : Not recommended for the treatment of diabetic ketoacidosis. ( 1 )